News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
335,377 Results
Type
Article (24606)
Company Profile (110)
Press Release (310661)
Multimedia
Podcasts (35)
Webinars (9)
Section
Business (116626)
Career Advice (1095)
Deals (17038)
Drug Delivery (77)
Drug Development (34751)
Employer Resources (153)
FDA (6501)
Job Trends (8114)
News (174912)
Policy (13136)
Tag
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (6)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1776)
Academic (2)
Accelerated approval (1)
Adcomms (22)
Allergies (37)
Alliances (25567)
ALS (40)
Alzheimer's disease (782)
Antibody-drug conjugate (ADC) (77)
Approvals (6541)
Artificial intelligence (156)
Autoimmune disease (11)
Automation (9)
Bankruptcy (107)
Best Places to Work (6621)
BIOSECURE Act (12)
Biosimilars (60)
Biotechnology (65)
Bladder cancer (36)
Brain cancer (13)
Breast cancer (118)
Cancer (1066)
Cardiovascular disease (81)
Career advice (944)
Career pathing (31)
CAR-T (72)
Cell therapy (213)
Cervical cancer (12)
Clinical research (27901)
Collaboration (500)
Compensation (106)
Complete response letters (9)
COVID-19 (1257)
CRISPR (28)
C-suite (172)
Cystic fibrosis (47)
Data (1079)
Decentralized trials (1)
Denatured (24)
Depression (20)
Diabetes (131)
Diagnostics (3588)
Digital health (9)
Diversity (7)
Diversity, equity & inclusion (40)
Drug discovery (66)
Drug pricing (52)
Drug shortages (6)
Duchenne muscular dystrophy (49)
Earnings (49342)
Editorial (16)
Employer branding (24)
Employer resources (130)
Events (49217)
Executive appointments (510)
FDA (7056)
Featured Employer (34)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (424)
Gene editing (56)
Generative AI (17)
Gene therapy (147)
GLP-1 (355)
Government (1949)
Grass and pollen (1)
Guidances (43)
Healthcare (8521)
Huntington's disease (13)
IgA nephropathy (11)
Immunology and inflammation (36)
Indications (16)
Infectious disease (1333)
Inflammatory bowel disease (76)
Inflation Reduction Act (7)
Influenza (26)
Intellectual property (52)
Interviews (160)
IPO (7898)
IRA (18)
Job creations (1774)
Job search strategy (838)
Kidney cancer (7)
Labor market (35)
Layoffs (208)
Leadership (14)
Legal (2427)
Liver cancer (35)
Lung cancer (184)
Lymphoma (80)
Machine learning (2)
Management (47)
Manufacturing (169)
MASH (15)
Medical device (6036)
Medtech (6040)
Mergers & acquisitions (9431)
Metabolic disorders (308)
Multiple sclerosis (48)
NASH (9)
Neurodegenerative disease (39)
Neuropsychiatric disorders (6)
Neuroscience (1052)
NextGen: Class of 2025 (3114)
Non-profit (2380)
Northern California (1241)
Now hiring (38)
Obesity (175)
Opinion (121)
Ovarian cancer (38)
Pain (40)
Pancreatic cancer (27)
Parkinson's disease (83)
Partnered (13)
Patents (89)
Patient recruitment (44)
Peanut (24)
People (36479)
Pharmaceutical (32)
Pharmacy benefit managers (1)
Phase I (7892)
Phase II (11771)
Phase III (10509)
Pipeline (660)
Policy (58)
Postmarket research (1197)
Preclinical (3869)
Press Release (63)
Prostate cancer (51)
Psychedelics (20)
Radiopharmaceuticals (121)
Rare diseases (163)
Real estate (3362)
Recruiting (59)
Regulatory (9678)
Reports (39)
Research institute (1566)
Resumes & cover letters (154)
Rett syndrome (2)
RNA editing (2)
RSV (30)
Schizophrenia (35)
Series A (85)
Series B (47)
Service/supplier (9)
Sickle cell disease (28)
Southern California (1047)
Special edition (8)
Spinal muscular atrophy (72)
Sponsored (16)
Startups (2312)
State (1)
Stomach cancer (7)
Supply chain (30)
Tariffs (14)
The Weekly (11)
United States (10799)
Vaccines (300)
Venture capitalists (30)
Weight loss (113)
Women's health (16)
Worklife (18)
Date
Today (86)
Last 7 days (465)
Last 30 days (1321)
Last 365 days (16034)
2025 (5165)
2024 (17674)
2023 (20587)
2022 (25923)
2021 (28724)
2020 (27001)
2019 (23912)
2018 (17775)
2017 (17566)
2016 (16683)
2015 (19258)
2014 (14075)
2013 (11526)
2012 (12502)
2011 (13061)
2010 (12068)
Location
Africa (480)
Alabama (24)
Alaska (4)
Arizona (91)
Arkansas (5)
Asia (21323)
Australia (3753)
California (2801)
Canada (958)
China (292)
Colorado (144)
Connecticut (99)
Delaware (95)
Europe (49836)
Florida (427)
Georgia (94)
Hawaii (1)
Idaho (28)
Illinois (224)
India (19)
Indiana (206)
Iowa (7)
Japan (118)
Kansas (39)
Kentucky (11)
Louisiana (9)
Maine (44)
Maryland (345)
Massachusetts (2117)
Michigan (132)
Minnesota (179)
Mississippi (1)
Missouri (45)
Montana (16)
Nebraska (14)
Nevada (28)
New Hampshire (36)
New Jersey (890)
New Mexico (19)
New York (887)
North Carolina (530)
North Dakota (8)
Northern California (1241)
Ohio (103)
Oklahoma (6)
Oregon (17)
Pennsylvania (553)
Puerto Rico (4)
Rhode Island (12)
South America (701)
South Carolina (11)
Southern California (1047)
Tennessee (45)
Texas (352)
Utah (85)
Virginia (58)
Washington D.C. (31)
Washington State (248)
West Virginia (1)
Wisconsin (39)
335,377 Results for "biodelivery sciences international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East
April 21, 2025
·
4 min read
Press Releases
Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine
April 22, 2025
·
8 min read
Press Releases
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
March 4, 2025
·
4 min read
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Job Trends
Report: 2025 U.S. Life Sciences Salary Report
March 25, 2025
·
1 min read
·
BioSpace Insights
Deals
Collegium to Acquire BioDelivery Sciences in an All-Cash Deal
BioDelivery Sciences International, Inc. today announced that it has entered into a definitive merger agreement for Collegium Pharmaceutical, Inc.
February 14, 2022
·
6 min read
Bio NC
BioDelivery Sciences International to Host ELYXYB™ Investor Day
BioDelivery Sciences International, Inc., a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced it will host a virtual ELYXYB™ Investor Day on Thursday, October 14, 2021, at 10:30am ET.
September 30, 2021
·
9 min read
Press Releases
ACP and Annals of Internal Medicine present breaking scientific news at ACP’s Internal Medicine Meeting 2025
April 4, 2025
·
4 min read
Bio NC
BioDelivery Sciences International Announces ELYXYB™ is Now Available in the U.S. for the Acute Treatment of Migraine
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), today announced the U.S. commercial launch and availability of ELYXYBTM (celecoxib oral solution), the first and only FDA-approved ready-to-use oral solution for the acute treatment of migraine with or without aura in adults.
February 24, 2022
·
8 min read
Press Releases
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
April 30, 2025
·
3 min read
1 of 33,538
Next
